Assessment of medication management ability in middle-aged and older adults with bipolar disorder.

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Abstract Text:

Colin A Depp,Ashley E Cain,Barton W Palmer,David J Moore,Lisa T Eyler,Barry D Lebowitz,Thomas L Patterson,Dilip V Jeste,

Medication nonadherence is a key clinical concern in bipolar disorder (BD) across the life span. Cognitive deficits in older adults with BD may hinder medication management ability, which, in turn, may lead to nonadherence. Using an innovative performance-based measure of medication management ability, the Medication Management Ability Assessment (MMAA), we compared performance of 29 middle-aged older community-dwelling outpatients with BD who were clinically stable (mean age, 61 years; SD, 11 years; range, 45-86 years) with those of 59 normal control subjects (NCs) and 219 outpatients with schizophrenia. The MMAA is a role-play task that simulates a medication regimen likely to be encountered by older adults. Within the BD group, we examined the relationships of MMAA scores to demographic, psychiatric symptoms severity, and the Mattis Dementia Rating Scale (DRS) scores. The BD group made 2.8 times the errors on the MMAA than NCs (BD group, 6.2; SD, 5.5 vs NCs, 2.2; SD, 2.5) and did not significantly differ from the Schizophrenia group in errors on the MMAA. Errors in the BD group were more likely to be taking in too few medications as taking in too many. Within the BD group, a significant correlation was seen between MMAA scores and the DRS Total score, but not with age, education, Brief Psychiatric Rating Scale, Hamilton Depression Rating Scale, number of psychiatric medications, or medical conditions. Among DRS subscales, the Memory Subscale correlated most strongly with MMAA errors. This small cross-sectional study suggests that deficits in medication management ability may be present in later-life BD. Neurocognitive deficits may be important in understanding problems with unintentional nonadherence.

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Publishing Authors By Initials

CA Depp,AE Cain,BW Palmer,DJ Moore,LT Eyler,BD Lebowitz,TL Patterson,DV Jeste,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Journal of clinical psychopharmacology

VOLUME: 28

Page Numbers: 225-9

Journal Abbreviation:

ISSN: 0271-0749

DAY: 17

MONTH: Apr

YEAR: 2008

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8109496

Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Assessment of medication management ability in middle-aged and older adults with bipolar disorder.

AFFILIATION: Department of Psychiatry, University of California, San Diego, CA, USA. cdepp@ucsd.edu

Country: United States

AGENCY: United States NIMH

GRANT: P30MH066248

ACRONYM: MH

MEDLINETA: J Clin Psychopharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Assessment of medication management ability in middle-aged and older adults with bipolar disorder Related Publications

• A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial.
• A review of performance-based measures of functional living skills.
• Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004.
• Anxiety disorders in a public mental health system: Clinical characteristics and service use patterns.
• Assessment of medication management ability in middle-aged and older adults with bipolar disorder.
• Brain response correlates of decisional capacity in schizophrenia: a preliminary FMRI study.
• Complementary and alternative medicine (CAM) use in geriatric psychiatry clinics.
• Complementary and alternative treatments for late-life depression, anxiety, and sleep disturbance: a review of randomized controlled trials.
• Costs of community-based public mental health services for older adults: variations related to age and diagnosis.
• Cultural formulation with attention to language and cultural dynamics in a mexican psychiatric patient treated in san diego, california.
• Deficits in cue detection and intention retrieval underlie prospective memory impairment in schizophrenia.
• Diagnostic variability for schizophrenia and major depression in a large public mental health care system dataset.
• Enhancing the informed consent process: a conceptual overview.
• Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders.
• Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients.
• Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.
• Initiation and use of public mental health services by persons with severe mental illness and limited english proficiency.
• Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study.
• Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders.
• Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
• Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
• Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects.
• Preliminary report: cerebral blood flow abnormalities in older schizophrenic patients.
• Public-academic partnerships: improving care for older persons with schizophrenia through an academic-community partnership.
• Publication of the International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia.
• Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.
• Recent advances in research on successful or healthy aging.
• Self-administered cognitive screening for a study of successful aging among community-dwelling seniors: a preliminary study.
• Successful aging: from phenotype to genotype.
• Unmet needs for mental health services for latino older adults: perspectives from consumers, family members, advocates, and service providers.